semaglutide and colonoscopy Prep: Provider Guidance – PlexusDx Impact of GLP-1 Receptor Agonists

August 7, 2021

Highlights Retatrutide is a novel triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors to regulate appetite and energy expenditure

The 'Science' They're Selling You: Why Rat Studies Aren't Proof Think of the FDA drug approval process like building a skyscraper

Boosts Energy and Endurance Enhances cellular energy production, helping to delay fatigue and improve training performance for active individuals

The net effect is reduced hunger, fewer calories consumed, and more stable blood glucoseall without restricting food choices or requiring extreme willpower